Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 4573452, 9 pages
https://doi.org/10.1155/2018/4573452
Research Article

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?

1Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland
2Department of Pathophysiology, Medical University of Silesia, Katowice, Poland
3Department of Internal Diseases and Oncological Chemotherapy, Medical University of Silesia, Katowice, Poland

Correspondence should be addressed to Aureliusz Kolonko; lp.pw@zsuinyru

Received 18 July 2017; Accepted 1 January 2018; Published 30 January 2018

Academic Editor: Takahisa Gono

Copyright © 2018 Kinga Krzyżowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kinga Krzyżowska, Aureliusz Kolonko, Piotr Giza, Jerzy Chudek, and Andrzej Więcek, “Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?,” BioMed Research International, vol. 2018, Article ID 4573452, 9 pages, 2018. https://doi.org/10.1155/2018/4573452.